-

The Weekly Hill Update – December 2025 #3
Below is this week’s congressional update by BakerHostetler’s Federal Policy team. We’ll continue to post in weeks when both chambers of Congress are in session….By: BakerHostetler
-

I Missed the Northern Lights Again, But the Insurance Industry Should Be Watching Carefully
On November 11 at 9:18 p.m., my phone erupted with the dings of incoming text messages advising me to go outside and “look north.” Those texts were soon followed by photos of the brilliant night sky above my small Massachusetts town….By: Zelle LLP
-

FDA Opens a CMS-linked Side Door: Use of Digital Health Devices Before Authorization Under the TEMPO Pilot
The U.S. Food and Drug Administration (FDA) announced the Technology-Enabled Meaningful Patient Outcomes for Digital Health Devices Pilot, or “TEMPO pilot,” on December 5, 2025, alongside a Federal Register notice seeking statements of interest for participation….By: Hogan Lovells
-

CFTC Launches Digital Assets Pilot Program and Issues Guidance on Tokenized Collateral
On December 8, the CFTC announced a series of actions to provide regulatory clarity and support responsible innovation in digital asset markets. Acting Chair Caroline Pham stated the actions implement recommendations from the president’s Working Group on Digital Asset Markets’ report (covered by InfoBytes here) and follow the CFTC’s Crypto Sprint initiative….By: Orrick, Herrington &…
-

Massachusetts High Court Weighs Instagram Lawsuit: Is Meta Getting Kids Hooked — And is That Illegal?
Last week, Massachusetts’ Supreme Judicial Court delved into a case with potentially national implications: should Meta platforms face a lawsuit alleging that Instagram’s design illegally hooks kids with addictive features?…By: Robinson+Cole Data Privacy + Security Insider
-

Robins Kaplan Secures $5 Million Jury Verdict in New Jersey’s First-Ever Clergy Sexual Abuse Trial Against Catholic Church Entity
In a historic legal outcome, the national trial firm Robins Kaplan LLP announced it has secured a $5 million compensatory jury verdict on behalf of a survivor of child sexual abuse, T.M., against the Order of St. Benedict of New Jersey, Inc., which operates the prestigious Delbarton School in Morristown….By: Robins Kaplan LLP
-

Memento Michigan Compiled Law § 600.2946(5): An Homage to Michigan’s Former Drug Immunity Law
In 1995, the Michigan Legislature enacted its Drug Immunity Law, which provided an absolute defense for pharmaceutical companies in product liability suits stemming from the safety and efficacy of their drug products, the only one of its kind in the nation….By: Butler Snow LLP
-

From the Courtroom to Capitol Hill: State Legislative Action on Failure-to-Warn Claims
When a company brings a new product to market, who has the authority to approve the product’s label and associated warnings? In most instances involving pharmaceutical drugs or medical devices, it’s the federal Food and Drug Administration (FDA)….By: Butler Snow LLP
-

Rule 45, Remote Testimony, and the Future of Subpoenas in Medical Device Litigation
Rule 45(c) of the Federal Rules of Civil Procedure protects witnesses from being compelled to travel long distances to testify at trial by placing geographical limits on the court’s subpoena power….By: Butler Snow LLP
-

Depo-Provera and Meningioma Brain Tumors: What Women Should Know About the Latest Lawsuits
Understanding the Link Between Depo-Provera and Meningioma – In recent years, several major medical studies have identified a potential association between the Depo-Provera birth control shot and the development of meningioma brain tumors….By: Hissey, Mulderig & Friend, PLLC